Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term interferon. Found 19 abstracts

Wong E, Xu RH, Rubio D, Lev A, Stotesbury C, Fang M, Sigal LJ. Migratory Dendritic Cells, Group 1 Innate Lymphoid Cells, and Inflammatory Monocytes Collaborate to Recruit NK Cells to the Virus-Infected Lymph Node. Cell Reports. 2018 Jul 03;24(1):142-54.   PMCID: PMC6232077
Kotredes KP, Thomas B, Gamero AM. The Protective Role of Type I Interferons in the Gastrointestinal Tract. Frontiers in immunology. 2017 Apr;8:410.   PMCID: PMC5382159
Kaiser WJ, Daley-Bauer LP, Thapa RJ, Mandal P, Berger SB, Huang CZ, Sundararajan A, Guo HY, Roback L, Speck SH, Bertin J, Gough PJ, Balachandran S, Mocarski ES. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proceedings of the National Academy of Sciences of the United States of America. 2014 May;111(21):7753-8.   PMCID: PMC4040608
Chen PR, Balachandran S. Development of interferon gamma-based immunocytokines targeting renal cancer. Oncoimmunology. 2013 Jul;2(7):e24964.   PMCID: PMC 3782162
Colt DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM. Melanoma. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):366-400.   PMCID: not NIH funded
Rose RW, Vorobyeva AG, Skipworth JD, Nicolas E, Rall GF. Altered levels of STAT1 and STAT3 influence the neuronal response to interferon gamma. Journal of neuroimmunology. 2007 Dec;192(1-2):145-56.
Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ, Bello CL, Theuer CP, George DJ, Rini BI. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology. 2006 Jan;24(1):16-24.
Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD. Sunitinib in patients with metastatic renal cell carcinoma. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2006 Jun;295(21):2516-24.
Licata A, Di Bona D, Schepis F, Shahied L, Craxi A, Camma C. When and how to treat acute hepatitis C?. Journal of Hepatology. 2003 Dec;39(6):1056-62.
Milling SW, Silvers WK, Sai T, Mintz B. Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models. Melanoma Research. 2002 Jun;12(3):221-30.
Tester WJ, Kim KM, Krigel RL, Bonomi PD, Glick JH, Asbury RF, Kirkwood JM, Blum RH, Schiller JH. A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer - An Eastern Cooperative Oncology Group study (PZ586). Lung Cancer. 1999 Sep;25(3):199-206.
Alpaugh RK, von Mehren M, Palazzo I, Atkins MB, Sparano JA, Schuchter L, Weiner LM, Dutcher JP. Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon. Medical Oncology. 1998 Sep;15(3):191-8.
Evans AA, O'Connell AP, Pugh JC, Mason WS, Shen FM, Chen GC, Lin WY, Dia A, M'Boup S, Drame B, London WT. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma. Cancer Epidemiology Biomarkers & Prevention. 1998 Jul;7(7):559-65.
Young RC. Metastatic renal-cell carcinoma: What causes occasional dramatic regressions?. New England Journal of Medicine. 1998 Apr 30;338(18):1305-6.
Alagiri M, Greenberg RE. Surgical palliation of incurable urologic cancer. Current Problems in Cancer. 1995 Nov;19(6):360-71.
Feitelson MA, Duan LX, Guo JH, Blumberg BS. X-Region Deletion Mutants Associated with Surface Antigen- Positive Hepatitis-B Virus-Infections. Gastroenterology. 1995 Jun;108(6):1810-9.
Mason WS, Cullen J, Saputelli J, Wu TT, Liu C, London WT, Lustbader E, Schaffer P, Oconnell AP, Fourel I, Aldrich CE, Jilbert AR. Characterization of the Antiviral Effects of 2' Carbodeoxyguanosine in Ducks Chronically Infected with Duck Hepatitis-B Virus. Hepatology (Baltimore, Md). 1994 Feb;19(2):398-411.
Comis RL. Extensive small cell lung cancer. Lung Cancer. 1993 Jan;9(SUPPL. 1).
Mason WS. The Problem of Antiviral Therapy for Chronic Hepadnavirus Infections. Journal of Hepatology. 1993 Jan;17:S137-S142.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term interferon

interferon interleukin-2 melanoma chemotherapy tyrosine kinase inhibitor etoposide cisplatin metastatic melanoma alpha dna cells in-vivo hepadnavirus infections trial liver-disease hepatocellular-carcinoma lung-cancer serum R24 NECROPTOSIS GENE-EXPRESSION reverse transcription gamma- cytotoxicity gd3 RANDOMIZED CONTROLLED TRIAL alpha-IFN biopsy sustained virological response monocytes intestine surgical excision necrosis renal cell carcinoma BRAIN glutathione-s-transferase iii-promoters signal transduction mutations H-2K(b) MLKL ACTIVATION phase-iii antitumor-activity seroconversion colony-stimulating factor combination NILE-VIRUS-INFECTION neuron Cd70 viral infection beta-interferon gene product(s) lymph node dissection factor receptor controlled trial KeyWords Plus: bladder-cancer acute hepatitis C randomized-trial tumor-suppressor gene cancer transmission MICE antiviral therapy ureteral obstruction META-ANALYSIS recombinant interleukin-2 therapy treatment cyclophosphamide CENTRAL-NERVOUS-SYSTEM CYTOKINE gene regulation NCCN Guidelines VIRUS-INFECTION PROGRAMMED NECROSIS adenocarcinoma lung small cell cancer anti-hbe 1993 n jkl-journal of dermatologic surgery and oncology-v19-p985 NK cells dendritic cells cirrhosis epidemiology monophosphate metastatic metastases chronic liver-disease skin hla DOMAIN-LIKE childhood radiation therapy NCCN Clinical Practice Guidelines vertical hepadnavirus RECOMBINANT INTERFERON-ALPHA-2B combination immunotherapy mouse urinary-bladder ganglioside viral-hepatitis SV40 large T antigen su11248 radiation-therapy prostate-cancer positron-emission-tomography phase-ii trial liver PROTECTION pathology hepatitis-b virus TNF STAT1 advanced prostate-cancer isolated limb perfusion primary melanomas Rip1 poxvirus STAT3 vhl adenine-arabinoside KAPPA-B ACTIVATION epithelium NATURAL BETA-INTERFERON stage-iii melanoma viral replication KAPPA-B malignant skin melanoma innate lymphoid cells General & Internal Medicine herpesvirus therapy interferon-gamma Multidisciplinary Sciences interleukin 2 MIXED LINEAGE KINASE virus-infection sentinel lymph node t-lymphocytes POSTTRANSFUSION NON-A cooperative-oncology-group primary cutaneous melanoma adjuvant therapy ectromelia virus REPLICATION VIRAL CLEARANCE arabinoside antigen loss killer-cells
Last updated on Friday, August 14, 2020